The serotonin syndrome

Netherlands Journal of Medicine

Volumn 62, Issue 9, 2004, Pages 309-313

  Bijl, D ^a  

^a NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; ANTIDEPRESSANT AGENT; BENZATROPINE; BROMOCRIPTINE; BUSPIRONE; CARBIDOPA; CLOMIPRAMINE; CLORAZEPATE; DEXTROMETHORPHAN; FLUOXETINE; LEVODOPA; LITHIUM; MEPROBAMATE; METOCLOPRAMIDE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PHENELZINE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAMADOL; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ANXIETY DISORDER; BRAIN STEM; CLINICAL FEATURE; CONVALESCENCE; DIAPHORESIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG HALF LIFE; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; HUMAN; INSOMNIA; MAJOR DEPRESSION; NAUSEA; REVIEW; SENSITIVITY ANALYSIS; SEROTONIN SYNDROME; SPINAL CORD; VOMITING;

BRAIN STEM; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; RECEPTORS, SEROTONIN; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; SPINAL CORD;

EID: 6444237189     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. CMAJ 2003;168:1439-42.
2. Marwijk HWJ, Bijl D, Adèr HJ, Haan M de. Antidepressant prescription for depression in general practice in the Netherlands. Pharm World Sci 2001;23:4-9.
3. Data from the Drug Utilisation Sub-Committee, Pharmaceutical Benefits Branch, Health Access and Financing Division, Commonwealth Department of Health and Ageing, Canberra, 2002.
4. Dijk L van. Het voorschrijven van antidepressiva in de huisartspraktijk in 1999 en 2000. Huisarts Wet 2002;45:289.
5. Bijl D, Verhoeven WMA. Antidepressants for depression. A critical analysis. [In Dutch]. Geneesmiddelenbulletin 2002;36:51-9.
6. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol 1999;13:100-9.
7. Verhoeven WMA, Noten JBGM, Tuinier S, Schendel FME van. Het serotoninesyndroom; een miskende complicatie van antidepressiva. Ned Tijdschr Geneeskd 1995;139:2073-5.
8. Jejoyeux M, Adès J, Rouillon F. Serotonin syndrome. CNS Drugs 1994;132:132-43.
9. Gillman PK. Serotonin syndrome: history and risk. Fundam Clin Pharmacol 1998;12:482-91.
10. Kempen GMJ van. Serotonine in de neurologie en de psychiatrie. Ned Tijdschr Geneeskd 1995;139:2084-8.
11. Reneman RS, Wenting GJ. Serotonine en hart- en vaatziekten. Ned Tijdschr Geneeskd 1995;139:2080-4.
12. Loenen A van (editor). Farmacotherapeutisch Kompas 2003. Amstelveen: College voor zorgverzekeringen, 2003.
13. Hall M, Buckley N. Serotonin syndrome. Aust Prescr 2003;26:62-3.
14. Jaunay E, Gaillac V, Guelfi JD. Syndrome sérotoninergique. Quel traitement et quand? Presse Med 2001;30:1695-700.
15. Radomski JW, Dursun SM, Revely MA, Kutcher SP. An exploratory approach to the serotonin syndrome; an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 2000;55:218-24.
16. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
17. Tiller JWG. Medicinal mishaps:serotonin states. Aust Prescr 1998;21:63.
18. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16:356-62.
19. Fava GA, Grandi S. Withdrawal syndromes after paroxetine and sertraline discontinuation. J Clin Psychopharmacol 1995;15:374-5.
20. Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 1995;57:507-33.
21. Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Practice 1999;49:871-4.
22. Uboge EE, Katirji B. Mirtazapine-induced serotonin syndrome. Clin Neuropharmacol 2003;26:54-7.
23. Skop BP, Finkelstein JA, Mareth TR, Magoon MR, Brown TM. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 1994;12:642-4.
24. Harvey AT, Burke M. Comment on: The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 1995;13:605-6.
25. Stockley IH. Drug interactions: a sourcebook of adverse interacations, their mechanisms, clinical importance and management. London: Pharmaceutical Press, 1999.
26. Green AR, Cross AJ, Goddwin GW. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethaphamine (MDMA or 'Ecstasy'). Psychopharmacology 1995;119:247-60.
27. Chan BS, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG. Serotonin syndrome resulting from drug interactions. Med J Aust 1998;169:523-5.
28. Hoes MJAJM, Zeijpveld JHB. Mirtazapine as treatment for serotonin syndrome. Pharmacopsychiatry 1996;29:81.